← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

Funds Holding in Top 10 Value Capital Flow New & Closed Increased & Reduced Calls & Puts Put/Call Ratio

New

Increased

Maintained

Reduced

Closed

Funds Holding 4,234

Funds Holding Change -26

Funds Holding Growth -0.6%

Value $845B

Holding in Top 10 675

Top 10 Change -79

Top 10 Growth -10%

Value Growth -6%

New 169

Increased 1,854

Reduced 1,852

Closed 139

Capital Inflow $25.7B

Capital Outflow $24.6B

Net Capital Flow +$1.07B

Capital Flow Change -$11.1B

Calls $10.6B

Puts $10.3B

Net Calls +$307M

Put/Call Ratio 0.97